 |
| BioNanomatrix's pioneering technology enables nanoscale identification and analysis of genomic DNA. |
BioNanomatrix has won the 2009 Frost & Sullivan Technology Innovation of the Year Award. The Philadelphia-based company develops revolutionary analytic and imaging platforms designed to dramatically reduce the time and cost needed to analyze DNA and other components of the genome.
The Frost & Sullivan Best Practices Awards identify companies, products, processes and executives that have achieved world-class performances.
BFTP invested $250,000 in BioNanomatrix in 2006, and in 2008 honored the company at the 14th Annual Ben Franklin Emerging Business Awards, known as the "Bennies," where the company won the Best Management Team category.
The company's unique nanochannel array technology enables rapid and cost-effective analysis of the entire human genome, delivering single-molecule sensitivity in a massively parallel format for genetic diagnostics, personalized medicine and biomedical research applications. |
